Longitudinal assessment of coronary plaque volume change related to glycemic status using serial coronary computed tomography angiography: A PARADIGM (Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging) substudy.


Journal

Journal of cardiovascular computed tomography
ISSN: 1876-861X
Titre abrégé: J Cardiovasc Comput Tomogr
Pays: United States
ID NLM: 101308347

Informations de publication

Date de publication:
Historique:
received: 11 06 2018
revised: 29 11 2018
accepted: 16 12 2018
pubmed: 26 12 2018
medline: 14 6 2019
entrez: 25 12 2018
Statut: ppublish

Résumé

Data on the impact of glycemic status on coronary plaque progression have been limited. This study evaluated the association between glycemic status and coronary plaque volume change (PVC) using coronary computed tomography angiography (CCTA). A total of 1296 subjects (61 ± 9, 56.9% male) who underwent serial CCTA with available glycemic status were enrolled and analyzed from the Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography IMaging (PARADIGM) registry. The median inter-scan period was 3.2 (2.6-4.4) years. Quantitative assessment of coronary plaques was performed at both scans. All participants were categorized into the following groups according to glycemic status: normal, pre-diabetes (pre-DM), and diabetes mellitus (DM). During the follow-up, significant differences in PVC (normal: 51.3 ± 83.3 mm DM had an incremental impact on coronary PP, but pre-DM appeared to have no significant association with an increased risk of coronary PP after adjusting for confounding factors. ClinicalTrials.govNCT02803411.

Sections du résumé

BACKGROUND BACKGROUND
Data on the impact of glycemic status on coronary plaque progression have been limited. This study evaluated the association between glycemic status and coronary plaque volume change (PVC) using coronary computed tomography angiography (CCTA).
METHODS METHODS
A total of 1296 subjects (61 ± 9, 56.9% male) who underwent serial CCTA with available glycemic status were enrolled and analyzed from the Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography IMaging (PARADIGM) registry. The median inter-scan period was 3.2 (2.6-4.4) years. Quantitative assessment of coronary plaques was performed at both scans. All participants were categorized into the following groups according to glycemic status: normal, pre-diabetes (pre-DM), and diabetes mellitus (DM).
RESULTS RESULTS
During the follow-up, significant differences in PVC (normal: 51.3 ± 83.3 mm
CONCLUSION CONCLUSIONS
DM had an incremental impact on coronary PP, but pre-DM appeared to have no significant association with an increased risk of coronary PP after adjusting for confounding factors.
CLINICAL TRIAL REGISTRATION BACKGROUND
ClinicalTrials.govNCT02803411.

Identifiants

pubmed: 30580992
pii: S1934-5925(18)30181-3
doi: 10.1016/j.jcct.2018.12.002
pii:
doi:

Substances chimiques

Biomarkers 0
Blood Glucose 0

Banques de données

ClinicalTrials.gov
['NCT02803411']

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

142-147

Informations de copyright

Copyright © 2018. Published by Elsevier Inc.

Auteurs

Ki-Bum Won (KB)

Department of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea; Department of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea.

Sang-Eun Lee (SE)

Department of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea; Yonsei-Cedars-Sinai Integrative Cardiovascular Imaging Research Center, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea.

Byoung Kwon Lee (BK)

Department of Cardiology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.

Hyung-Bok Park (HB)

Yonsei-Cedars-Sinai Integrative Cardiovascular Imaging Research Center, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea; Department of Cardiology, Catholic Kwandong University International St. Mary's Hospital, Incheon, South Korea.

Ran Heo (R)

Yonsei-Cedars-Sinai Integrative Cardiovascular Imaging Research Center, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea; Department of Cardiology, Hanyang University Seoul Hospital, Hanyang University College of Medicine, Seoul, South Korea.

Asim Rizvi (A)

Department of Radiology, New York-Presbyterian Hospital and Weill Cornell Medical College, New York, NY, USA; Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Fay Y Lin (FY)

Department of Radiology, New York-Presbyterian Hospital and Weill Cornell Medical College, New York, NY, USA.

Amit Kumar (A)

Department of Radiology, New York-Presbyterian Hospital and Weill Cornell Medical College, New York, NY, USA.

Martin Hadamitzky (M)

Department of Radiology and Nuclear Medicine, German Heart Center Munich, Munich, Germany.

Yong-Jin Kim (YJ)

Seoul National University Hospital, Seoul, South Korea.

Ji Min Sung (JM)

Department of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea; Yonsei-Cedars-Sinai Integrative Cardiovascular Imaging Research Center, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea.

Edoardo Conte (E)

Centro Cardiologico Monzino, IRCCS, Milan, Italy.

Daniele Andreini (D)

Centro Cardiologico Monzino, IRCCS, Milan, Italy.

Gianluca Pontone (G)

Centro Cardiologico Monzino, IRCCS, Milan, Italy.

Matthew J Budoff (MJ)

Department of Medicine, Los Angeles Biomedical Research Institute, Torrance, CA, USA.

Ilan Gottlieb (I)

Department of Radiology, Casa de Saude São Jose, Rio de Janeiro, Brazil.

Eun Ju Chun (EJ)

Department of Radiology, Seoul National University Bundang Hospital, Sungnam, South Korea.

Filippo Cademartiri (F)

Cardiovascular Imaging Center, SDN IRCCS, Naples, Italy.

Erica Maffei (E)

Department of Radiology, Area Vasta 1/ASUR Marche, Urbino, Italy.

Hugo Marques (H)

UNICA, Unit of Cardiovascular Imaging, Hospital da Luz, Lisboa, Portugal.

Jonathon A Leipsic (JA)

Department of Medicine and Radiology, University of British Columbia, Vancouver, BC, Canada.

Sanghoon Shin (S)

Department of Cardiology, National Health Insurance Service Ilsan Hospital, South Korea.

Jung Hyun Choi (JH)

Department of Cardiology, Busan University Hospital, Busan, South Korea.

Renu Virmani (R)

Department of Pathology, CVPath Institute, Gaithersburg, MD, USA.

Habib Samady (H)

Department of Cardiology, Emory University School of Medicine, Atlanta, GA, USA.

Kavitha Chinnaiyan (K)

Department of Cardiology, William Beaumont Hospital, Royal Oak, MI, USA.

Gilbert L Raff (GL)

Department of Cardiology, William Beaumont Hospital, Royal Oak, MI, USA.

Peter H Stone (PH)

Department of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Daniel S Berman (DS)

Department of Imaging and Medicine, Cedars Sinai Medical Center, Los Angeles, CA, USA.

Jagat Narula (J)

Icahn School of Medicine at Mount Sinai, Mount Sinai Heart, Zena and Michael A. Wiener Cardiovascular Institute, And Marie-Josee and Henry R. Kravis Center for Cardiovascular Health, New York, NY, USA.

Leslee J Shaw (LJ)

Department of Radiology, New York-Presbyterian Hospital and Weill Cornell Medical College, New York, NY, USA.

Jeroen J Bax (JJ)

Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.

James K Min (JK)

Department of Radiology, New York-Presbyterian Hospital and Weill Cornell Medical College, New York, NY, USA.

Hyuk-Jae Chang (HJ)

Department of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea; Yonsei-Cedars-Sinai Integrative Cardiovascular Imaging Research Center, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea. Electronic address: hjchang@yuhs.ac.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH